We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+16.5%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$570M
AUM Growth
+$32M
Cap. Flow
+$8.01M
Cap. Flow %
1.4%
Top 10 Hldgs %
66.95%
Holding
31
New
4
Increased
5
Reduced
8
Closed
5

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$42.6M
2
EXAS
Exact Sciences
EXAS
+$23.3M
3
INSM icon
Insmed
INSM
+$19.9M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$19.3M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$9.6M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$28.4M
2
TMDX icon
Transmedics
TMDX
+$17.5M
3
NTRA icon
Natera
NTRA
+$16.1M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$13.4M
5
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 98.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$22.7B
$53.4M 9.36%
167,499
-12,000
-7% -$3.18M
NTRA icon
2
Natera
NTRA
$45.9B
$51.3M 9%
474,114
-158,600
-25% -$16.1M
ICLR icon
3
Icon
ICLR
$12.8B
$46.9M 8.22%
149,590
– –
UNH icon
4
UnitedHealth
UNH
$371B
$44.3M 7.76%
+86,900
New +$42.6M
ARGX icon
5
argenx
ARGX
$54.2B
$38.2M 6.7%
88,890
+4,300
+5% +$1.65M
INSM icon
6
Insmed
INSM
$29.4B
$34.4M 6.04%
+513,700
New +$19.9M
ILMN icon
7
Illumina
ILMN
$29B
$33.3M 5.83%
318,754
-8,925
-3% -$1M
DXCM icon
8
DexCom
DXCM
$33.1B
$31.3M 5.48%
275,718
-9,200
-3% -$1.16M
IQV icon
9
IQVIA
IQV
$39.8B
$25.8M 4.52%
121,895
– –
EXAS
10
DELISTED
Exact Sciences
EXAS
$23M 4.03%
544,200
+423,200
+350% +$23.3M
RARE icon
11
Ultragenyx Pharmaceutical
RARE
$2.64B
$21.6M 3.78%
524,500
+224,800
+75% +$9.6M
TMDX icon
12
Transmedics
TMDX
$3.07B
$20M 3.51%
132,861
-145,794
-52% -$17.5M
BMRN icon
13
BioMarin Pharmaceuticals
BMRN
$13.3B
$19.1M 3.35%
+231,800
New +$19.3M
ALNY icon
14
Alnylam Pharmaceuticals
ALNY
$29B
$18.5M 3.25%
76,256
+27,900
+58% +$4.4M
INSP icon
15
Inspire Medical Systems
INSP
$1.73B
$18.3M 3.21%
136,603
+14,400
+12% +$2.73M
GH icon
16
Guardant Health
GH
$22.4B
$18.1M 3.18%
626,909
-103,300
-14% -$2.41M
PRCT icon
17
Procept Biorobotics
PRCT
$1.24B
$15.7M 2.75%
257,089
-80,129
-24% -$4.77M
AGIO icon
18
Agios Pharmaceuticals
AGIO
$1.95B
$14.3M 2.5%
330,830
– –
ISRG icon
19
Intuitive Surgical
ISRG
$139B
$12.6M 2.21%
28,290
-7,300
-21% -$2.91M
CRSP icon
20
PUT
CRISPR Therapeutics
CRSP
$5.17B
$10.6M 1.87%
197,000
– –
FDMT icon
21
4D Molecular Therapeutics
FDMT
$582M
$9.72M 1.7%
462,911
– –
LNTH icon
22
Lantheus
LNTH
$6.59B
$3.47M 0.61%
43,200
– –
VKTX icon
23
Viking Therapeutics
VKTX
$4.02B
$2.39M 0.42%
45,000
– –
HOWL icon
24
Werewolf Therapeutics
HOWL
$18.6M
$1.71M 0.3%
700,000
– –
IMCR icon
25
Immunocore
IMCR
$1.73B
$1.57M 0.28%
46,300
– –
1
2

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Eagle Health Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Eagle Health Investments held 31 positions worth $570M, up 5.9% from $538M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Eagle Health Investments's Q2 2024 filing shows 4 new, 5 increased, 8 reduced and 5 closed positions. Its largest new stake was UnitedHealth: 86,900 shares worth $44.3M. The largest sale was Danaher, an estimated $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 98% a quarter earlier.

  • Eagle Health Investments's largest Q2 2024 buy was UnitedHealth: 86,900 shares worth $44.3M.
  • Eagle Health Investments added most to Exact Sciences in Q2 2024, an estimated $23.3M increase.
  • Eagle Health Investments's biggest Q2 2024 reduction was Transmedics, cutting an estimated $17.5M.
  • Eagle Health Investments fully exited Danaher in Q2 2024, selling an estimated $28.4M.
  • Eagle Health Investments's ten largest holdings make up 67% of its $570M portfolio in Q2 2024.
  • Eagle Health Investments opened 4 new positions and closed 5 in Q2 2024.
  • Eagle Health Investments's portfolio value rose 5.9% quarter-over-quarter to $570M.

Based on Eagle Health Investments's 13F filing for Q2 2024, filed 13 Aug 2024.